1-hexadecanoyl-2-(4Z,7Z,10Z,13Z,16Z-docosapentaenoyl)-sn-glycero-3-phosphocholine

Metabolite details

Identifier

MWXAIAMSOXOQJK-JIXVGTEKSA-N

InChI Key

MWXAIAMSOXOQJK-JIXVGTEKSA-N

IUPAC name

(2R)-2-[(4Z,7Z,10Z,13Z,16Z)-docosa-4,7,10,13,16-pentaenoyloxy]-3-(hexadecanoyloxy)propyl 2-(trimethylammonio)ethyl phosphate

Preferred name

1-hexadecanoyl-2-(4Z,7Z,10Z,13Z,16Z-docosapentaenoyl)-sn-glycero-3-phosphocholine

INN name

—

Synonym

PC(16:0/22:5)

ChEBI

CHEBI:84795

Reactome pathways

• No Reactome pathways listed for this metabolite.

Observed in studies

• A multi-omics approach to study peroxisome proliferator-activated receptor mediated regulation of lipid metabolism in Atlantic cod (Gadus morhua)
• Metabolic Dynamics of In Vitro CD8+ T Cell Activation.
• Metabolic characterization of the natural progression of chronic hepatitis B (Lipid assays).
• Lipidomic Changes in the Liver of Beagle Dogs Associated with Toxocara canis Infection
• Sexual dimorphism in the fetal cardiac response to maternal nutrient restriction.
• Fatty acid oxidation protects cancer cells from apoptosis through increasing mitochondrial membrane lipids
• Transcriptomic dynamics control rapid transition of core crop functions in 'lactating' pigeon
• Transcript variants of long-chain acyl-CoA synthase 1 have distinct roles in sheep lipid metabolism

Observed in differential profiles

• Control_Plasma_vs_WY-14,643_Plasma
• G3_Experimental_Sample_0h_vs_G11_Experimental_Sample_96h
• Control_vs_Immune_Tolerant
• Control_vs_Immune_Tolerant
• Control_vs_Immune_Tolerant
• Control_12h_vs_Toxocara canis_12h
• Control_Female_vs_Restricted_Female
• Hanks_balanced_salt_solution_vs_doxycycline
• Male_19_days_vs_Male_1_day
• Knockdown_vs_Control
• Knockdown_vs_Control